Search

everythinglearnresearchcommunity

for

Search:↓

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Skin symptoms can indicate endocrine disorders and have various treatments.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

A diabetic cat with another gland issue got better after treatment with cabergoline, no longer needing insulin.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

No cure for female pattern hair loss, but various effective treatments exist.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Finasteride increased hair count and regrowth in men with hair loss but also caused more sexual side effects than placebo.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.